PegIFN alfa-2a
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PegIFN alfa-2a, covering 2012-04-20 to 2012-04-20. Get the full timeline:
Most recent: Clinical Trial Update: PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR) [Phase 4]